Brief: Australian Clinical Labs Sees FY Results At Lower End Of Underlying EBIT Range Previously Provided
21/05/2024 02:19
May 21 (Reuters) - Australian Clinical Labs Ltd
ACL.AX :
* AUSTRALIAN CLINICAL LABS SEES FY RESULTS AT LOWER END OF
UNDERLYING EBIT RANGE PREVIOUSLY PROVIDED OF A$60M TO A$65M
Further company coverage: ACL.AX
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Australian Clinical Labs
See all newsBrief: Australian Clinical Labs Appoints Deloitte As Auditor
Australia's Optiscan rises after imaging more than 80 cases in ACL study
Australian Clinical Labs falls to over two-week low on trading ex-dividend
Australian Clinical Labs at 6-month high on upbeat full-year results, guidance
Brief: Australian Clinical Labs Says It Expects FY27 Revenue Of A$745-765 Million